Figure 3.
Figure 3. Lytic activity, IFN-γ release, and tetramer binding in pp65/pp150-MVA IVS cultures. IVS using pp65/pp150-MVA was performed with HLA A*0201 donors 001, 009, 011, and 007, and for HLA B*0702. (A) Cytotoxic activity detected after IVS is shown for each donor. ▦ indicates background lysis to autologous LCLs loaded with p53149-157; ♦ indicates lysis of autologous LCLs pulsed with pp65495-503 (donors 001, 009, and 011) or pp65417-426 (donor 007); • indicates lysis of pp150945-955-pulsed autologous LCLs of donor 011. (B) Tetramer binding levels in CD8+ cells from fresh PBMCs (○) and pp65/pp150-MVA IVS cultures (•). pp65495-503 tetramers were used for donors 001, 009, and 011, while donor 007 was tested using pp65417-426 tetramers. CD8+ T-cell binding to HIV pol464-472 tetramers was subtracted. (C) Percentage IFN-γ release from CD8+ cells of fresh PBMCs (○) and pp65/pp150-MVA IVS cultures (•) detected in ICC. Peptides used during ICC incubation were p53149-157 and pp65495-503 for HLA A*0201 donors and pp65417-426 for HLA A*0702 donor 007. For each donor, percentages of IFN-γ CD8+ cells to irrelevant p53149-157 peptide were subtracted from the corresponding specific values.

Lytic activity, IFN-γ release, and tetramer binding in pp65/pp150-MVA IVS cultures. IVS using pp65/pp150-MVA was performed with HLA A*0201 donors 001, 009, 011, and 007, and for HLA B*0702. (A) Cytotoxic activity detected after IVS is shown for each donor. ▦ indicates background lysis to autologous LCLs loaded with p53149-157; ♦ indicates lysis of autologous LCLs pulsed with pp65495-503 (donors 001, 009, and 011) or pp65417-426 (donor 007); • indicates lysis of pp150945-955-pulsed autologous LCLs of donor 011. (B) Tetramer binding levels in CD8+ cells from fresh PBMCs (○) and pp65/pp150-MVA IVS cultures (•). pp65495-503 tetramers were used for donors 001, 009, and 011, while donor 007 was tested using pp65417-426 tetramers. CD8+ T-cell binding to HIV pol464-472 tetramers was subtracted. (C) Percentage IFN-γ release from CD8+ cells of fresh PBMCs (○) and pp65/pp150-MVA IVS cultures (•) detected in ICC. Peptides used during ICC incubation were p53149-157 and pp65495-503 for HLA A*0201 donors and pp65417-426 for HLA A*0702 donor 007. For each donor, percentages of IFN-γ CD8+ cells to irrelevant p53149-157 peptide were subtracted from the corresponding specific values.

Close Modal

or Create an Account

Close Modal
Close Modal